![]() Folx estimates it has 5,000 clients on testosterone, and Plume estimates that 30% to 40% of its 11,000 users are on testosterone. And telehealth companies that offer treatments like testosterone are working to come up with contingency plans.įolx and Plume are two of the most prominent startups providing direct-to-consumer gender-affirming hormone therapy. Still, President Joe Biden's recent declaration that the pandemic was "over" is the latest sign that COVID-era flexibility won't last forever. The order that allowed for these looser regulations is set to expire on October 13, though it's been extended repeatedly, and many expect the Biden administration to extend it yet again. In response to the pandemic, the DEA loosened regulations, making it easier to get controlled substances like testosterone and the ADHD drug Adderall online. The Drug Enforcement Administration classifies testosterone as a controlled substance, and before the COVID-19 pandemic it was impossible to get it solely through telehealth. For thousands of people like Kole, who get their testosterone treatments online, this convenient, safe access may be at risk if rules around telehealth return to a pre-pandemic status quo. For many, this care, which is used to help some transgender people feel more like their true gender, is a crucial and often life-saving treatment that can increase happiness and decrease feelings of depression and anxiety. Several hundred thousand people use testosterone for gender-affirming hormone therapy, according to an estimate from the Center for Applied Transgender Studies. It could become more difficult to get hormone therapy online It often indicates a user profile.Ī game developer named Kole says he prefers to get care online. Account icon An icon in the shape of a person's head and shoulders.
0 Comments
Leave a Reply. |